Spots Global Cancer Trial Database for albumin bound paclitaxel
Every month we try and update this database with for albumin bound paclitaxel cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Clinical Study of Nab-paclitaxel Combined With Toripalimab in Local Advanced or Metastatic G/GEJ Carcinoma | NCT04443036 | Gastric Carcino... | Albumin-Bound P... Toripalimab | 18 Years - 70 Years | China Medical University, China | |
| Study of Radiotherapy Combined With Albumin Bound Paclitaxel and Nedaplatin for Locally Advanced NSCLC | NCT04524299 | Non-small Cell ... | chest radiation... Concurrent chem... Concurrent chem... | 18 Years - 75 Years | Sun Yat-sen University | |
| Neoadjuvant Dose-dense EC Followed by ABX With PD-1 for Triple Negative Breast Cancer Patients | NCT04418154 | Triple Negative... | epirubicin hydr... Cyclophosphamid... Albumin bound p... Toripalimab | 18 Years - 70 Years | Fudan University | |
| A Study of Anti-PD-L1 Antibody in Neoadjuvant Chemotherapy of Esophageal Squamous Cell Carcinoma. | NCT04460066 | Esophageal Canc... | anti-PD-L1 anti... albumin bound p... cisplatin placebo radical resecti... | 18 Years - 75 Years | Lee's Pharmaceutical Limited | |
| A Study of Anti-PD-L1 Antibody ZKAB001 Combined With Albumin-bound Paclitaxel in Advanced Urothelial Carcinoma | NCT04603846 | Advanced Urothe... | anti-PD-L1 anti... albumin bound p... | 18 Years - | Lee's Pharmaceutical Limited | |
| Safety and Efficacy Study of Abraxane as Maintenance Treatment After Abraxane Plus Carboplatin in 1st Line Stage IIIB / IV Squamous Cell Non-small Cell Lung Cancer | NCT02027428 | Squamous Cell C... | Abraxane (Induc... Carboplatin (In... Abraxane (Maint... Best Supportive... Abraxane (Induc... Carboplatin (In... Best Supportive... | 18 Years - | Celgene | |
| A Study of Anti-PD-L1 Antibody ZKAB001 Combined With Albumin-bound Paclitaxel in Advanced Urothelial Carcinoma | NCT04603846 | Advanced Urothe... | anti-PD-L1 anti... albumin bound p... | 18 Years - | Lee's Pharmaceutical Limited | |
| Albumin Bound Paclitaxel Plus S-1 as the First Line Chemotherapy in Advanced or Recurrent Gastric Cancer | NCT02229058 | Gastric Cancer | Albumin Bound P... S-1 | 18 Years - 90 Years | Sun Yat-sen University | |
| Albumin Bound Paclitaxel Plus S-1 as the First Line Chemotherapy in Advanced or Recurrent Gastric Cancer | NCT02229058 | Gastric Cancer | Albumin Bound P... S-1 | 18 Years - 90 Years | Sun Yat-sen University | |
| Study of Radiotherapy Combined With Albumin Bound Paclitaxel and Nedaplatin for Locally Advanced NSCLC | NCT04524299 | Non-small Cell ... | chest radiation... Concurrent chem... Concurrent chem... | 18 Years - 75 Years | Sun Yat-sen University | |
| Nab-Paclitaxel Treatment in Advanced Squamous Cell Carcinoma of Lung | NCT01236716 | Carcinoma, Non-... | Albumin paclita... Gemcitabine plu... | 18 Years - 85 Years | Chinese Society of Lung Cancer | |
| Clinical Study of Nab-paclitaxel Combined With Toripalimab in Local Advanced or Metastatic G/GEJ Carcinoma | NCT04443036 | Gastric Carcino... | Albumin-Bound P... Toripalimab | 18 Years - 70 Years | China Medical University, China | |
| Nab-Paclitaxel Treatment in Advanced Squamous Cell Carcinoma of Lung | NCT01236716 | Carcinoma, Non-... | Albumin paclita... Gemcitabine plu... | 18 Years - 85 Years | Chinese Society of Lung Cancer |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
